Literature DB >> 11760590

Managing stable chronic obstructive pulmonary disease.

.   

Abstract

Over 26,000 people died of chronic obstructive pulmonary disease (COPD) in England and Wales in 1999. The disease is a common cause of consultations in primary care and accounts for as many as 1 in 8 medical admissions. Patients with stable COPD, the focus of this article, experience chronic symptoms such as breathlessness, cough, sputum production, wheeze and chest tightness, which worsen slowly over time. We do not deal here with the management of severe acute exacerbations, which are caused by an additional (often infective) process.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11760590     DOI: 10.1136/dtb.2001.391181

Source DB:  PubMed          Journal:  Drug Ther Bull        ISSN: 0012-6543


  2 in total

Review 1.  Respiratory medicine.

Authors:  Hilary Pinnock
Journal:  Br J Gen Pract       Date:  2004-07       Impact factor: 5.386

2.  Long acting beta2 agonists for stable chronic obstructive pulmonary disease with poor reversibility: a systematic review of randomised controlled trials.

Authors:  Don Husereau; Vijay Shukla; Michel Boucher; Shaila Mensinkai; Robert Dales
Journal:  BMC Pulm Med       Date:  2004-08-31       Impact factor: 3.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.